Hardik Shah(@AIStockSavvy):$HIMS | BofA Securities maintains 𝐍𝐞𝐮𝐭𝐫𝐚𝐥 on 𝐇𝐢𝐦𝐬 & 𝐇𝐞𝐫𝐬, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟑𝟔 𝐟𝐫𝐨𝐦 $𝟐𝟓, 'This update is negative for the HIMS' Analyst sees a recent FDA update as negative for HIMS's peptide optionality narrative, lowering the probability of a clear legal pathway for compounding.

Hardik Shah

@AIStockSavvy

Software Developer | AI-Powered News Insights, Earnings Reports and Analyst Ratings | Follow for Savvy Insights, Not Advice #AI# #StockMarket#

Joined September 2009

1.2K Following 39K Followers

Hardik Shah@AIStockSavvy

2026.07.01 17:12

$HIMS | BofA Securities maintains 𝐍𝐞𝐮𝐭𝐫𝐚𝐥 on 𝐇𝐢𝐦𝐬 & 𝐇𝐞𝐫𝐬, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟑𝟔 𝐟𝐫𝐨𝐦 $𝟐𝟓, 'This update is negative for the HIMS' Analyst sees a recent FDA update as negative for HIMS's peptide optionality narrative, lowering the probability of a clear legal pathway for compounding.